Use access key #2 to skip to page content.
$2.04 -0.09 (-4.23%)
9/4/2008 4:00 PM

XOMA Limited (XOMA)

CAPS Rating:
***

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating XOMA

Add Stock to Watchlist

What the Community Thinks

Total Members

282 Outperforms
24 Underperforms
 

All-Stars

40 Outperforms
9 Underperforms
 

Wall Street

9 Outperforms
0 Underperforms
 

Members bullish on XOMA are also bullish on:

Members bearish on XOMA are also bearish on:

Ticker Tags

Biotechnology (294), Micro Cap (4824)
Suggest a tag

XOMA Limited At A Glance

Current Price: $2.04
Last Trade Time: 9/4/2008 4:00 PM
Open: $0.00
Previous Close: $2.13
Daily Range: $2.03 - $2.13
52-Week Range: $1.58 - $4.39
Volume: 546,042
Market Cap: $281.87M
P/E Ratio: 78.67
Compare Our Special Broker Offers!

Stock Trends

XOMA VS S&P 500 (SPY)

XOMA 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for XOMA

More Headlines...

Top Bull Pitch

Recs

1

XOMA Limited (XOMA)

Avatar talon444 (< 20) Submitted: 9/14/07 9:59 PM

A "risky" play in the biopharm area, but this one is grounded on solid sucessess rather than fairytales. Of course the question is can they keep it up and it is far from a safe stock. Love the stock though if you looking for a smallcap in this industry.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

3

XOMA Limited (XOMA)

Avatar BrianRuth (99.69) Submitted: 3/05/07 2:16 AM

Calling BS on this one. It would be great if they could help cancer with recombinant whatever, but I think 9 out of 10 microcap companies in this space will go bankrupt.

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 50 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (XOMA)

Avatar jungleeater (< 20) Submitted: 8/25/08 5:05 PM : Outperform Start Price: $1.99 XOMA Score: 4.90

XOMA has a couple of good products in the works---R&D is a snail pace endeavor...and with the Government thrown into the mix some drugs take forever to materialize---better to err for the sake of safety but .....

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (XOMA)

Avatar HighRisk41 (< 20) Submitted: 8/17/08 9:20 PM : Outperform Start Price: $2.28 XOMA Score: -5.62

This buy could be considered "high risk", but with the company already receiving royalties from drugs such as LUCENTIS and RAPTIVA to name a few. Plus they have two new promising drugs (xoma 052 & xoma 629) entering later stages of research as we speak. Not to mention the buy-out possibilities.This company has no where to go but UP!!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (XOMA)

Avatar rvood (25.06) Submitted: 7/23/08 12:49 AM : Outperform Start Price: $2.29 XOMA Score: -7.90

Good pipeline, royalties working, good relationships with big Pharma, would speculate as to a possible buyout.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (XOMA)

Avatar WILLWYKO777 (< 20) Submitted: 7/06/08 6:05 PM : Outperform Start Price: $1.66 XOMA Score: 25.09

already have drug pipeline royalities, drugs in the wings are very promising, they are a buyout canidate

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (XOMA)

Avatar thecyberguy (40.56) Submitted: 6/05/08 2:36 PM : Underperform Start Price: $1.92 XOMA Score: -17.48

HAHAHAHAH

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 50 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 9 of 9  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackPacificGrow 84.24 07/29/08 Outperform NS $1.94+5.15% 0%+5.15
TrackSusquehanna 52.76 05/13/08 Outperform NS $2.15-5.12%-11.66%+6.54
TrackLadenburg 97.68 05/12/08 Outperform NS $2.14-4.67%-11.62%+6.94
TrackPZK < 20 03/25/08 Outperform NS $2.65-23.02%-7.62%-15.40
TrackRBCCapMkts 91.34 03/05/08 Outperform NS $2.61-21.84%-7.03%-14.81
TrackCanaccord 90.01 11/27/07 Outperform NS $3.08-33.77%-12.49%-21.26
TrackJimCramer 82.41 10/03/07 Outperform 3W $3.85-47.01%-19.35%-27.67
TrackRodmanRen 52.05 01/24/07 Outperform NS $2.51-18.73%-12.78%-5.95

Results 1 - 9 of 9  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners